Eversept Partners, LP Ptc Therapeutics, Inc. Transaction History

Eversept Partners, LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 13, 2019	SELL	$33.82 - $48.17 $1.64 Million - $2.34 Million	-48,600 Closed	0 $0
Q2 2019 Nov 08, 2023	SELL	$35.42 - $45.0 $1.84 Million - $2.34 Million	-52,000 Reduced 51.69%	48,600 $2.19 Million
Q2 2019 Aug 13, 2019	SELL	$35.42 - $45.0 $1.84 Million - $2.34 Million	-52,000 Reduced 51.69%	48,600 $2.19 Million
Q1 2019 Nov 08, 2023	BUY	$28.09 - $39.49 $2.83 Million - $3.97 Million	100,600 New	100,600 $3.79 Million
Q1 2019 May 14, 2019	BUY	$28.09 - $39.49 $2.83 Million - $3.97 Million	100,600 New	100,600 $3.79 Million

258

77.4M

179K

536K

Ticker PTCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,541,000
Market Cap $3.9B
Description
PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...

Get notified when there are updates to the investment portfolio of Eversept Partners, LP, based on Form 13F filings with the SEC.

Stay updated on Eversept Partners, LP with notifications on news.